Industries de la santé
21 Mars 2017
The immune thrombocytopenia (ITP) market across the seven major countries of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to grow from $928 million in 2015 to $985 million by 2025, representing a very modest overall compound annual growth rate of 0.6%, according to research and consulting firm GlobalData. |The company’s latest report states that the ITP space will see...
Plus d'articles...
- $100 billion of revenues up for grabs for drug manufacturers by 2020 as patents for key biologics expire
- La clinique Saint-George de Nice implante son 1er sternum CERAMIL®
- La responsabilité de l'hôpital envers les patients et les personnels de santé
- DBV Technologies annonce la fin du recrutement des enfants allergiques à l'arachide dans l'étude REALISE